Acer Therapeutics/ US00444P1084 /
2023-11-08 9:59:30 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.89USD | - | 25,148 Turnover: 22,053.79 |
-Bid Size: - | -Ask Size: - | 0.91 | 0.86 |
GlobeNewswire
03-28
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
GlobeNewswire
01-29
TScan Therapeutics Appoints Seasoned Industry Executive Jason A. Amello as Chief Financial Officer
GlobeNewswire
01-04
Zevra Therapeutics Appoints Global Medical Leader, Adrian Quartel, M.D., FFPM, as Chief Medical Offi...
GlobeNewswire
2023-11-20
Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rar...
GlobeNewswire
2023-11-17
Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition C...
GlobeNewswire
2023-11-07
Zevra Therapeutics Reports Corporate Updates and Third Quarter 2023 Financial Results
GlobeNewswire
2023-11-02
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholder...
GlobeNewswire
2023-10-13
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIN, TWNK, PNT, ACER
GlobeNewswire
2023-10-08
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NXGN, AVTA, SPLK, ACER
GlobeNewswire
2023-09-18
SHAREHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – AGE, NEWR, CCF, AC...
GlobeNewswire
2023-09-15
Moore Kuehn Encourages AGE, ACER, NXGN, and SUM Investors to Contact Law Firm
GlobeNewswire
2023-09-12
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – VRTV, HCCI, RETA, ...
GlobeNewswire
2023-09-06
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – AGE, ESTE, ACER, C...
GlobeNewswire
2023-09-05
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AgeX Therap...
GlobeNewswire
2023-08-31
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Acer Therap...
GlobeNewswire
2023-08-31
Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Com...
GlobeNewswire
2023-08-30
Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA...
GlobeNewswire
2022-03-07
Acer Therapeutics Secures up to $48.5 Million in Convertible Note and Secured Loan Financing Facilit...
GlobeNewswire
2022-03-02
Acer Therapeutics Reports Q4 and Full Year 2021 Financial Results and Provides Corporate Update
GlobeNewswire
2022-02-22
Acer Therapeutics Announces Appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer
GlobeNewswire
2022-01-27
Acer Therapeutics and Relief Therapeutics Announce Presentation of Four ACER-001 Posters at the Upco...
GlobeNewswire
2021-12-22
Acer Therapeutics to Participate in January 2022 Virtual Investor Conferences